Determination of clinically therapeutic endoxifen concentrations based on efficacy from human MCF7 breast cancer xenografts

By Gong Inna  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 61-69

Springer Publishing Company

Access to resources Recommend Favorite

Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer

By Guppy Amy   Jamal-Hanjani Mariam   Pickering Lisa  

Future Oncology, Vol. 7, Iss. 6, 2011-06 ,pp. : 727-736

Future Medicine

Access to resources Recommend Favorite

Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice

By Ruddy Kathryn   Desantis Stephen   Gelman Rebecca   Wu Alan   Punglia Rinaa   Mayer Erica   Tolaney Sara   Winer Eric   Partridge Ann   Burstein Harold  

Breast Cancer Research and Treatment, Vol. 141, Iss. 3, 2013-10 ,pp. : 421-427

Springer Publishing Company

Access to resources Recommend Favorite

Breast Cancer: Current Molecular Therapeutic Targets and New Players

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 2, 2017-01 ,pp. : 152-163

Bentham Science Publishers

Access to resources Recommend Favorite

HER2 and Trastuzumab: Impact of a New Standard Agent on Local Control and Surgery for Breast Cancer

By Ziogas Dimosthenis  

Annals of Surgical Oncology, Vol. 15, Iss. 12, 2008-12 ,pp. : 3614-3615

Springer Publishing Company

Access to resources Recommend Favorite